Sawyer Falduto Asset Management’s AbbVie ABBV Stock Holding History

Sawyer Falduto Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$196K	Hold	780	–	–	0.16%	40
2026 Q1	$170K	Hold	780	–	–	0.16%	40
2025 Q4	$178K	Buy	+780	New	+$178K	0.16%	37

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sawyer Falduto Asset Management's ABBV Position: Q2 2026 in Review

Sawyer Falduto Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 780 shares worth $196K. The position accounts for 0.16% of the portfolio, ranked #40.

Sawyer Falduto Asset Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sawyer Falduto Asset Management held 780 shares of AbbVie worth $196K as of Q2 2026.
Sawyer Falduto Asset Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.16% of Sawyer Falduto Asset Management's portfolio in Q2 2026, its #40 holding.
Sawyer Falduto Asset Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sawyer Falduto Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.